Article info

Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis

Authors

  1. Correspondence to Dr Jianguo Li, Rheumatology and Immunology, Capital Institute of Pediatrics, Beijing 100020, China; jianguo_li6{at}hotmail.com
View Full Text

Citation

Ding Y, Huang B, Wang Y, et al
Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis

Publication history

  • Received July 20, 2020
  • Revised September 24, 2020
  • Accepted October 13, 2020
  • First published October 28, 2020.
Online issue publication 
March 11, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.